Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines

Publisher： Karger

E-ISSN： 1423-0224|63|1|1-7

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.63, Iss.1, 2010-10, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Ghrelin Levels and the Effects of Antidepressants in Major Depressive Disorder and Panic Disorder

By  

Neuropsychobiology, Vol. 66, Iss. 3, 2012-08 ,pp. : 185-192

Karger

Access to resources Recommend Favorite

Antioxidant Enzyme and Malondialdehyde Levels in Patients with Panic Disorder

By  

Neuropsychobiology, Vol. 46, Iss. 4, 2003-02 ,pp. : 186-189

Karger

Access to resources Recommend Favorite

Are Respiratory Abnormalities Specific for Panic Disorder? A Meta-Analysis

By  

Neuropsychobiology, Vol. 70, Iss. 1, 2014-09 ,pp. : 52-60

Karger

Access to resources Recommend Favorite

Relative Hyperhomocysteinemia in Patients with Panic Disorder: A Case-Control Study

By  

Neuropsychobiology, Vol. 62, Iss. 3, 2010-07 ,pp. : 164-170

Karger

Access to resources Recommend Favorite

Pain Thresholds as a Putative Functional Test for Cerebral Laterality in Major Depressive Disorder and Panic Disorder1

By  

Neuropsychobiology, Vol. 48, Iss. 3, 2003-11 ,pp. : 146-151

Karger

Access to resources Recommend Favorite